Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takayoshi Owada

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Modern Rheumatology|July 25, 2009
Subarachnoid hemorrhage in systemic lupus erythematosus in Japan: two case reports and a review of the literatureTakayoshi Owada, Kentaro Takahashi, Yasuhiko Kita
The Journal of Rheumatology|February 13, 2013
Dr. Owada, et al, replyTakayoshi Owada, Reika Maezawa, Kazuhiro Kurasawa
Modern Rheumatology|May 22, 2010
Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosusKazuhiro Kurasawa, Satoko Arai, Takayoshi Owada, et al.
Modern Rheumatology|September 18, 2012
Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositisSatoko Arai, Kazuhiro Kurasawa, Reika Maezawa, et al.
The Journal of Rheumatology|July 4, 2012
Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositisTakayoshi Owada, Reika Maezawa, Kazuhiro Kurasawa, et al.
Modern Rheumatology|April 3, 2012
Positivity for anti-RNP antibody is a risk factor for adverse effects caused by trimethoprim-sulfamethoxazole, a prophylactic agent for P. jiroveci pneumonia, in patients with connective tissue diseasesReika Maezawa, Kazuhiro Kurasawa, Satoko Arai, et al.
International Immunopharmacology|May 13, 2022
LAT1-specific inhibitor ameliorates severe autoimmune arthritis in SKG mouseTakayoshi Owada, Kazuhiro Kurasawa, Hitoshi Endou, et al.
Open Access Rheumatology : Research and Reviews|June 17, 2024
Safety of Tocilizumab on Rheumatoid Arthritis in Patients with Interstitial Lung DiseaseNaotatsu Otsuji, Kumiya Sugiyama, Takayoshi Owada, et al.
Modern Rheumatology|June 21, 2016
Intensive immunosuppressive therapy for endogenous lipoid pneumonia associated with rheumatoid arthritisHiroko Morita, Satoko Arai, Kazuhiro Kurasawa, et al.
Rheumatology (Oxford, England)|July 31, 2018
Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositisKazuhiro Kurasawa, Satoko Arai, Yumeko Namiki, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Modern Rheumatology|July 25, 2009
Subarachnoid hemorrhage in systemic lupus erythematosus in Japan: two case reports and a review of the literatureTakayoshi Owada, Kentaro Takahashi, Yasuhiko Kita
The Journal of Rheumatology|February 13, 2013
Dr. Owada, et al, replyTakayoshi Owada, Reika Maezawa, Kazuhiro Kurasawa
Modern Rheumatology|May 22, 2010
Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosusKazuhiro Kurasawa, Satoko Arai, Takayoshi Owada, et al.
Modern Rheumatology|September 18, 2012
Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositisSatoko Arai, Kazuhiro Kurasawa, Reika Maezawa, et al.
The Journal of Rheumatology|July 4, 2012
Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositisTakayoshi Owada, Reika Maezawa, Kazuhiro Kurasawa, et al.
Modern Rheumatology|April 3, 2012
Positivity for anti-RNP antibody is a risk factor for adverse effects caused by trimethoprim-sulfamethoxazole, a prophylactic agent for P. jiroveci pneumonia, in patients with connective tissue diseasesReika Maezawa, Kazuhiro Kurasawa, Satoko Arai, et al.
International Immunopharmacology|May 13, 2022
LAT1-specific inhibitor ameliorates severe autoimmune arthritis in SKG mouseTakayoshi Owada, Kazuhiro Kurasawa, Hitoshi Endou, et al.
Open Access Rheumatology : Research and Reviews|June 17, 2024
Safety of Tocilizumab on Rheumatoid Arthritis in Patients with Interstitial Lung DiseaseNaotatsu Otsuji, Kumiya Sugiyama, Takayoshi Owada, et al.
Modern Rheumatology|June 21, 2016
Intensive immunosuppressive therapy for endogenous lipoid pneumonia associated with rheumatoid arthritisHiroko Morita, Satoko Arai, Kazuhiro Kurasawa, et al.
Rheumatology (Oxford, England)|July 31, 2018
Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositisKazuhiro Kurasawa, Satoko Arai, Yumeko Namiki, et al.
Pageof 3